Alternative Treatments to Clozapine
50 Questions
1 Views

Choose a study mode

Play Quiz
Study Flashcards
Spaced Repetition
Chat to lesson

Podcast

Play an AI-generated podcast conversation about this lesson

Questions and Answers

Mianserin combined with FGA (30mg/day) has extensive RCT evidence supporting its efficacy.

False

Minocycline 200mg/day may have anti-inflammatory and neuroprotective effects based on one open study and one RCT.

True

Mirtazapine 30mg/day combined with an antipsychotic has consistently positive results in RCTs.

False

N-acetylcysteine 2g/day combined with an antipsychotic has been shown to provide benefits in both negative symptoms and rates of akathisia.

<p>True</p> Signup and view all the answers

Olanzapine 30-60mg/day is a typical antipsychotic and is associated with minor side effects.

<p>False</p> Signup and view all the answers

Omega 3 triglycerides have extensive data supporting their efficacy.

<p>False</p> Signup and view all the answers

Ondansetron 8mg/day combined with an antipsychotic has a conclusive effect on cognition.

<p>False</p> Signup and view all the answers

Paliperidone LAI has been shown to improve clinical outcomes in patients switched from clozapine.

<p>False</p> Signup and view all the answers

Olanzapine combined with risperidone may benefit some patients after the sequential failure of each drug alone.

<p>True</p> Signup and view all the answers

High dose Olanzapine is well-tolerated and does not lead to metabolic changes.

<p>False</p> Signup and view all the answers

Bexarotene 75mg/day is effective for treating positive symptoms in non-refractory patients.

<p>True</p> Signup and view all the answers

Blonanserin has been licensed worldwide as an atypical antipsychotic.

<p>False</p> Signup and view all the answers

Celecoxib + risperidone has been associated with decreased cardiovascular mortality.

<p>False</p> Signup and view all the answers

CBT should always be considered as a non-drug therapy for schizophrenia.

<p>True</p> Signup and view all the answers

Deep Brain Stimulation targeting the nucleus accumbens has shown effectiveness in all TRS patients in studies.

<p>False</p> Signup and view all the answers

Donepezil, a glycine NMDA agonist, has shown positive results in one RCT.

<p>True</p> Signup and view all the answers

Ginkgo biloba is often effective on its own without combining with any antipsychotic.

<p>False</p> Signup and view all the answers

Estradiol has shown benefits in women of child-bearing age for positive symptoms of schizophrenia.

<p>True</p> Signup and view all the answers

Famotidine showed improvement in all symptom domains in a six-month study.

<p>False</p> Signup and view all the answers

One RCT comparing standard with high dose lurasidone found it as effective for TRS patients when given up to 24 weeks.

<p>True</p> Signup and view all the answers

There is very weak evidence supporting the use of NMDA receptor modulators as adjuncts in treating refractory schizophrenia.

<p>True</p> Signup and view all the answers

Polypharmacy involving non-clozapine antipsychotics has strong evidence of effectiveness in treating refractory schizophrenia.

<p>False</p> Signup and view all the answers

Electroconvulsive therapy (ECT) has the best evidence as an adjunct treatment to clozapine compared to other physical treatments for refractory schizophrenia.

<p>True</p> Signup and view all the answers

Monotherapy using non-clozapine antipsychotics such as aripiprazole has a strong evidence base for its efficacy.

<p>False</p> Signup and view all the answers

Adjunctive antidepressants like mirtazapine and SSRIs show moderate benefits in treating cognitive symptoms in refractory schizophrenia.

<p>False</p> Signup and view all the answers

The combination of lamotrigine and antipsychotics is supported by strong evidence for treating refractory schizophrenia.

<p>False</p> Signup and view all the answers

Anti-inflammatory agents as adjuncts to antipsychotics may have possible benefits in negative and cognitive symptoms, but the sample sizes in studies have been large.

<p>False</p> Signup and view all the answers

The use of CBT in treating refractory schizophrenia has conflicting findings with only small effects observed.

<p>True</p> Signup and view all the answers

Allopurinol, used at doses of 300-600mg/day, has three positive randomized controlled trials (RCTs) supporting its efficacy when combined with an antipsychotic.

<p>True</p> Signup and view all the answers

Amisulpride has multiple large-scale randomized controlled studies supporting its efficacy at doses up to 1200mg/day.

<p>False</p> Signup and view all the answers

Antipsychotic polypharmacy has robust randomized controlled trial data supporting its effectiveness.

<p>False</p> Signup and view all the answers

Aripiprazole has shown a moderate effect in patients resistant to risperidone or olanzapine in a single randomized controlled study at doses of 15-30mg/day.

<p>True</p> Signup and view all the answers

Higher doses of Aripiprazole, even up to 120mg/day, have been utilized in studies.

<p>False</p> Signup and view all the answers

Asenapine's efficacy has primarily been supported by two case reports when used in combination with another antipsychotic.

<p>True</p> Signup and view all the answers

The use of propentofylline paired with risperidone has been suggested to have activity against positive symptoms.

<p>True</p> Signup and view all the answers

Quetiapine and amisulpride combination treatment resulted in high efficacy based on extensive clinical trials with numerous patients.

<p>False</p> Signup and view all the answers

Topiramate has been shown to induce weight loss in patients receiving antipsychotic treatment.

<p>True</p> Signup and view all the answers

Clinical improvement with pimavanserin was observed only when combined with clozapine.

<p>False</p> Signup and view all the answers

Sertindole demonstrated clear and consistent effectiveness in all trials on patients with schizophrenia.

<p>False</p> Signup and view all the answers

Raloxifene is a selective estrogen receptor modulator that may offer benefits without the long-term risks associated with estradiol.

<p>True</p> Signup and view all the answers

Yokukansan, when used alone, showed significant efficacy in managing schizophrenia.

<p>False</p> Signup and view all the answers

Risperidone LAI had similar plasma levels for the 50mg and 100mg doses as compared to a 4-6mg/day oral risperidone.

<p>False</p> Signup and view all the answers

Clozapine treatment should be delayed or withheld in cases where treatment resistance has been established.

<p>False</p> Signup and view all the answers

The practice of using successive antipsychotic medications instead of clozapine is supported by research.

<p>False</p> Signup and view all the answers

Long-term data on efficacy and safety/tolerability are generally available for antipsychotic medications.

<p>False</p> Signup and view all the answers

Olanzapine is rarely used as antipsychotic monotherapy in practice.

<p>False</p> Signup and view all the answers

The risk-benefit balance of combined antipsychotic medication regimens is well established.

<p>False</p> Signup and view all the answers

Depot/LAI antipsychotic preparations are not an option for treating treatment-resistant schizophrenia.

<p>False</p> Signup and view all the answers

Minocycline and ondansetron have high toxicity and poor tolerability.

<p>False</p> Signup and view all the answers

All treatments listed in the text are well-established and widely used for treating schizophrenia.

<p>False</p> Signup and view all the answers

Study Notes

Alternative Treatments to Clozapine

  • Allopurinol 300-600mg/day: increases adenosinergic transmission, may reduce dopamine effects, supported by three positive RCTs.
  • Amisulpride (up to 1200mg/day): single small open study.
  • Antipsychotic polypharmacy: various antipsychotics in combination, data limited, mainly in case reports and open studies.
  • Aripiprazole (15-30mg/day): single randomized controlled study, moderate effect in patients resistant to risperidone or olanzapine.
  • Asenapine (+ antipsychotic): two case reports.
  • Pimavanserin (+ antipsychotics): clinical improvement in 10 patients, six of whom failed to respond to clozapine.
  • Propentofylline + risperidone (900mg + 6mg/day): one RCT suggests some activity against positive symptoms.
  • Quetiapine: very limited evidence, clinical experience not encouraging, high doses (>1200mg/day) used but no more effective.
  • Quetiapine + amisulpride: single naturalistic observation of 19 patients, suggested useful benefit.
  • Quetiapine + haloperidol: two case reports.
  • Raloxifene 60-120mg/day (+ antipsychotic): selective oestrogen receptor modulator, may offer benefits of estradiol without long-term risks, one case report in postmenopausal treatment-resistant schizophrenia.
  • Riluzole 100mg/day + risperidone up to 6mg/day: glutamate modulating agent, one RCT demonstrated improvement in negative symptoms.
  • Risperidone 4-8mg/day: doubtful efficacy in true treatment-refractory schizophrenia, but some supporting evidence.
  • Sarcosine (2g/day) (+ antipsychotic): enhances glycine action, supported by two RCTs.
  • Sertindole (12-24mg/day): one large RCT suggested good effect and equivalence to risperidone, another RCT showed no effect at all when added to clozapine.

Table 1.37 (Continued)

  • Mianserin + FGA 30mg/day: 5HT antagonist, one small positive RCT.
  • Minocycline 200mg/day (+ antipsychotic): may be anti-inflammatory and neuroprotective, one open study and one RCT suggest good effect on negative and cognitive symptoms.
  • Mirtazapine 30mg/day (+ antipsychotic): 5HT antagonist, two RCTs, one negative and one positive, effect seems to be mainly on positive symptoms.
  • N acetylcysteine 2g/day (+ antipsychotic): one RCT suggests small benefits in negative symptoms and rates of akathisia, another RCT showed benefits in chronic schizophrenia.

Treatments for Schizophrenia

  • Bexarotene 75mg/day (+ antipsychotic): retinoid receptor agonist, one RCT suggests worthwhile effect on positive symptoms.
  • Blonanserin (+ antipsychotic): atypical antipsychotic licensed in Japan and Korea, one case series found it to be effective and well-tolerated.
  • CBT: non-drug therapies should always be considered.
  • Celecoxib + risperidone (400mg + 6mg/day): COX-2 inhibitors modulate immune response and may prevent glutamate-related cell death, one RCT showed useful activity in all main symptom domains.
  • Deep Brain Stimulation (DBS): effectiveness of nucleus accumbens and subgenual anterior cingulate cortex targeted DBS demonstrated in 4 of 7 patients with TRS, three RCTs, one negative and two positive, suggesting a small effect on cognitive and negative symptoms.

Refractory Schizophrenia — Alternatives to Clozapine

  • Monotherapy using non-clozapine antipsychotics in standard or high doses: evidence of efficacy for any antipsychotic other than clozapine in refractory schizophrenia is sparse.
  • Non-clozapine antipsychotic polypharmacy: polypharmacy is common in clinical practice, evidence from controlled studies limited, but open studies and real-world data suggest some effectiveness.
  • Anti-inflammatory agents as adjuncts to antipsychotics: possible benefits in negative and cognitive symptoms, but sample sizes have been small.
  • NMDA receptor modulators as adjuncts: rarely used in clinical practice, may have some benefit in negative symptoms.
  • Physical treatments: ECT, rTMS, tDCS, DBS, best evidence for ECT as adjunct to clozapine.
  • Adjunctive antidepressants: limited data available, suggests small benefits in negative and cognitive symptoms.
  • Adjunctive antiseizure medications: data difficult to interpret, including clozapine and non-clozapine antipsychotics, modest benefits at best.
  • Psychological therapies: conflicting findings, effects small.

Treatment of Refractory Schizophrenia

  • Clozapine has the strongest evidence for efficacy in treating schizophrenia that has proven refractory to standard antipsychotic medication.
  • Clozapine treatment should not be delayed or withheld when treatment resistance has been established.

Alternative Treatment Options

  • In cases where clozapine cannot be used, other drugs or drug combinations may be tried, but outcomes are often disappointing.
  • Long-term data on efficacy and safety/tolerability are generally lacking.

Antipsychotic Medication Regimens

  • There is no distinction between treatment regimens, but it is wise to use single drugs before trying multiple drug options.
  • Olanzapine is often used as antipsychotic monotherapy, usually in dosages above the licensed range.

Combination Therapy

  • Adding a second antipsychotic (e.g., amisulpride) may be a possible next step, but the risk-benefit balance of combined antipsychotic medication regimens remains unclear.

Unconventional Agents

  • Minocycline and ondansetron have low toxicity and good tolerability, making them potential treatment options.

Depot/LAI Antipsychotic Preparations

  • Depot/LAI antipsychotic preparations are an option when the avoidance of covert non-adherence is a clinical priority.

Experimental Treatments

  • Treatments like glycine, D-serine, and sarcosine are somewhat experimental and difficult to obtain.
  • Particular care should be taken when prescribing off-label and informing patients of potential adverse effects.

Future Directions

  • Non-clozapine treatment of refractory schizophrenia is an active area of research.
  • Glutamatergic drugs and 5HT2A inverse agonists may hold promise for future treatment options.

Studying That Suits You

Use AI to generate personalized quizzes and flashcards to suit your learning preferences.

Quiz Team

Description

This quiz covers alternative treatments to clozapine, including allopurinol, amisulpride, antipsychotic polypharmacy, and aripiprazole. Learn about their effects and efficacy in treating psychiatric disorders.

More Like This

Antipsychotic Depot Preparations in Psychiatry
10 questions
Oxford shoter- antipsychotics
205 questions
Use Quizgecko on...
Browser
Browser